HomeIONS • NASDAQ
add
Ionis Pharmaceuticals Inc
$40.69
Makalipas ang Oras ng Trabaho:(0.54%)-0.22
$40.47
Sarado: Ago 6, 5:51:28 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$43.05
Sakop ng araw
$40.66 - $42.87
Sakop ng taon
$23.95 - $50.43
Market cap
6.49B USD
Average na Volume
2.07M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 452.05M | 100.69% |
Gastos sa pagpapatakbo | 90.62M | 39.18% |
Net na kita | 123.55M | 286.45% |
Net profit margin | 27.33 | 192.90% |
Kita sa bawat share | 0.85 | 452.98% |
EBITDA | 142.68M | 326.46% |
Aktuwal na % ng binabayarang buwis | -0.02% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.29B | 9.95% |
Kabuuang asset | 2.99B | 10.92% |
Kabuuang sagutin | 2.35B | -3.05% |
Kabuuang equity | 631.72M | — |
Natitirang share | 159.39M | — |
Presyo para makapag-book | 10.84 | — |
Return on assets | 12.06% | — |
Return on capital | 13.82% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 123.55M | 286.45% |
Cash mula sa mga operasyon | 151.34M | 226.24% |
Cash mula sa pag-invest | -120.07M | -292.26% |
Cash mula sa financing | 1.25M | -51.23% |
Net change in cash | 33.11M | 160.32% |
Malayang cash flow | 98.52M | 197.53% |
Tungkol
Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics. The company has three commercially approved medicines: Spinraza, Tegsedi, and Waylivra, and has four drugs in pivotal studies: tominersen for Huntington's disease, tofersen for SOD1-ALS, AKCEA-APO-LRx for cardiovascular disease, and AKCEA-TTR-LRx for all forms of TTR amyloidosis.
The company was named Isis Pharmaceuticals until December 2015. Wikipedia
Itinatag
1989
Headquarters
Website
Mga Empleyado
1,069
